Global Biliary Stents Market By Product (Biliary Metal Stents, Biliary Plastic Stents), End-User (Hospitals, Ambulatory Surgical Centers), Application (Biliopancreatic Leakages, Pancreatic Cancer, Benign Biliary Strictures, Gallstones), & Region for 2024-2031

Biliary Stents Market Valuation – 2024-2031

Increasing prevalence of gallstone-related diseases and cancers affecting the bile ducts is propelling the adoption of biliary stent. Thus, rising geriatric population prone to biliary disorders and advancements in minimally invasive surgeries is driving the market size surpass USD 342.19 Million valued in 2024 to reach a valuation of around USD 490.36 Million by 2031.

In addition to this, growing preference for endoscopic procedures over traditional surgeries, expanding healthcare infrastructure in developing regions supporting diagnostic and treatment capabilities, and ongoing innovations in stent materials is enabling the market grow at a CAGR of 4.60% from 2024 to 2031.

Biliary Stents MarketDefinition/ Overview

Biliary stents are medical devices used to maintain the patency of the bile ducts, which can become obstructed due to various conditions such as gallstones, cancers, strictures, or surgeries. These stents are typically made of metal alloys, plastic polymers, or bioabsorbable materials and are inserted into the bile ducts via endoscopic or percutaneous procedures. They provide a conduit for bile drainage, relieve obstruction, and facilitate the flow of bile from the liver to the intestine, thereby alleviating symptoms and preventing complications associated with biliary obstruction.

Biliary stents find extensive application in the management of benign and malignant conditions affecting the bile ducts. In benign cases, such as gallstone-related strictures or postsurgical complications, stents help in maintaining bile flow and preventing further blockages. For malignant conditions like bile duct cancers or pancreatic cancers causing biliary obstruction, stents are used to palliate symptoms such as jaundice, itching, and abdominal pain, improving quality of life. The versatility of biliary stents extends to both temporary and permanent placements, depending on the underlying condition and patient needs.

The future of biliary stents lies in technological advancements aimed at enhancing their efficacy, safety, and patient outcomes. Innovations in stent materials, such as biodegradable polymers and drug-eluting coatings, aim to improve biocompatibility and reduce the risk of complications like stent migration or tissue ingrowth.

What are the Growth Factors in the Biliary Stents Market?

The drivers of the biliary stents market are multifaceted and driven by several key factors. Firstly, the increasing prevalence of gallstone-related diseases and cancers affecting the bile ducts is a significant driver. As the global population ages and lifestyles change, there is a rise in conditions such as gallstones and pancreatic cancers, necessitating interventions like biliary stent placements to manage bile duct obstructions effectively.

Also, advancements in medical technology and minimally invasive surgical techniques have expanded the use of biliary stents. Endoscopic procedures, which are less invasive than traditional surgical interventions, are increasingly preferred for their ability to place stents directly into the bile ducts with reduced recovery times and complications. This trend is boosting the adoption of biliary stents as a primary treatment option.

In addition to this, the growing preference for outpatient and day-case procedures is driving market growth. Biliary stent placements can often be performed on an outpatient basis, reducing hospital stays and healthcare costs while improving patient convenience. This shift towards ambulatory care is enhancing the accessibility and affordability of biliary stent treatments for patients worldwide.

Furthermore, increasing healthcare expenditure and infrastructure development in emerging economies are expanding access to advanced medical treatments, including biliary stent placements. Improved healthcare facilities and rising awareness among healthcare providers about the benefits of early intervention for biliary disorders are contributing to market growth in these regions.

Will High Costs of Biliary Stents Restrain Its Application?

The biliary stents market faces several significant restraints that impact its growth and adoption across various regions. Cost constraints play a significant role in limiting the widespread adoption of biliary stents. The expenses associated with stent placement procedures, including the cost of the device, hospitalization, and follow-up care, can be substantial. High costs may restrict access to treatment, particularly in developing regions or for patients with limited financial resources, thereby affecting market growth and patient outcomes.

Also, complications associated with biliary stents such as migration, occlusion, and infection pose significant challenges. These complications can lead to adverse patient outcomes, necessitate additional procedures for stent retrieval or replacement, and increase healthcare costs. Managing these risks effectively remains a critical concern for healthcare providers and patients alike.

Also, the limited long-term efficacy of biliary stents is a notable restraint. While stents provide immediate relief by alleviating bile duct obstructions, especially in cases of cancers or strictures, they may require periodic replacements due to issues like stent blockage or tissue ingrowth. This can impact patient quality of life and necessitate frequent medical interventions, adding to healthcare expenses and logistical challenges.

Category-Wise Acumens

Which Factors Contributing Dominance Biliary Metal Stents Segment in Biliary Stents Market?

Biliary metal stents have emerged as a dominant technology in the management of bile duct obstructions due to several key advantages. Firstly, their durable construction from materials like stainless steel or nitinol provides structural integrity, making them suitable for long-term placement in benign and malignant conditions affecting the bile ducts. This durability allows metal stents to withstand external compression and maintain patency more effectively compared to their plastic counterparts.

Also, biliary metal stents offer larger lumens and a broader range of diameters, facilitating better bile drainage and reducing the risk of recurrent blockages. This feature is particularly beneficial in treating strictures caused by cancers or chronic diseases where maintaining adequate bile flow is crucial for patient comfort and symptom management.

Furthermore, the ease of deployment during endoscopic procedures enhances procedural efficiency and reduces operating time. Metal stents can be accurately positioned using advanced endoscopic techniques, ensuring optimal placement and minimizing the risk of complications such as stent misplacement or migration.

Which Factors Enhance the Use of Biliary Stents in Ambulatory Surgical Centers?

Ambulatory Surgical Centers (ASCs) are increasingly dominating the biliary stents market due to several compelling factors. Firstly, ASCs offer a cost-effective alternative to traditional hospital settings for performing outpatient procedures, including biliary stent placements. The lower overhead costs associated with ASCs translate to reduced procedural expenses for patients and healthcare providers, making them financially attractive for both parties.

Also, ASCs provide efficient and streamlined care pathways for patients undergoing biliary stent procedures. These centers are equipped with state-of-the-art endoscopic and imaging technologies, enabling precise stent placements under optimal conditions. This setup enhances procedural accuracy, minimizes complications, and supports quicker recovery times compared to hospital-based settings.

In addition to this, the convenience and accessibility of ASCs play a significant role in their market dominance. Patients benefit from shorter wait times, flexible scheduling options, and a patient-centered environment that enhances overall satisfaction. Moreover, ASCs are often located closer to residential areas, making them more accessible for patients seeking outpatient care for biliary disorders.

Furthermore, regulatory frameworks increasingly support the expansion of ASCs, facilitating their growth in the healthcare landscape. Government initiatives and policies that promote outpatient surgery and reduce bureaucratic barriers contribute to the proliferation of ASCs specializing in advanced procedures like biliary stent placements.

Gain Access into Biliary Stents Market Report Methodology

Country/Region-wise Acumens

Will Well-Established Healthcare Infrastructure in North America Mature Biliary Stents Market?

North America asserts dominance in the global biliary stents market for several compelling reasons. Firstly, the region benefits from a well-established healthcare infrastructure and advanced medical technologies, fostering early adoption and widespread availability of biliary stent procedures. Major advancements in endoscopic techniques and imaging technologies in countries like the United States and Canada have significantly enhanced the precision and efficacy of biliary stent placements.

Also, the prevalence of biliary disorders such as gallstones, bile duct cancers, and pancreatic diseases is relatively high in North America. This demographic trend drives substantial demand for biliary stent placements as a primary intervention for managing obstructive symptoms and improving patient outcomes.

Furthermore, supportive regulatory frameworks in North America facilitate rapid innovation and market entry for new biliary stent technologies. Stringent yet predictable regulatory processes ensure patient safety while enabling timely approvals and commercialization of advanced stent designs, including biodegradable materials and drug-eluting coatings.

Also, North America’s healthcare system encourages collaborations between healthcare providers, research institutions, and industry stakeholders. This collaborative approach fosters continuous advancements in biliary stent technology, clinical research, and procedural standards, ensuring patients receive state-of-the-art care and optimal treatment outcomes.

Will Rising Industrialization Enhance Adoption of Biliary Stents  in Asia Pacific?

Asia-Pacific is experiencing rapid growth in the biliary stents market due to several key factors. Firstly, the region’s increasing healthcare infrastructure and rising healthcare expenditures are expanding access to advanced medical treatments, including biliary stent procedures. Countries like China, India, and Japan are investing significantly in healthcare infrastructure development, enhancing diagnostic capabilities, and promoting the adoption of minimally invasive procedures.

Also, the prevalence of biliary disorders, such as gallstones and bile duct cancers, is on the rise in Asia-Pacific due to changing lifestyles, dietary habits, and aging populations. This demographic shift is driving the demand for biliary stent placements as essential interventions to manage obstructive symptoms and improve patient quality of life.

Furthermore, technological advancements and innovations in medical devices are accelerating the growth of the biliary stents market in Asia-Pacific. Local and international manufacturers are introducing advanced stent designs, including biodegradable materials, drug-eluting coatings, and improved deployment techniques, tailored to meet the region’s specific healthcare needs and patient preferences.

Competitive Landscape

The competitive landscape of the biliary stents market is characterized by intense competition among a diverse array of medical device manufacturers and healthcare providers. Key factors influencing competition include technological advancements in stent design, materials, and deployment techniques aimed at improving efficacy and patient outcomes. Regulatory compliance and market approvals play a crucial role in market entry, with stringent standards ensuring product safety and efficacy. Additionally, strategic collaborations, partnerships, and mergers are shaping the competitive dynamics, enabling companies to expand their market presence and enhance their product portfolios. Market players are also focused on addressing healthcare disparities, optimizing cost-effectiveness, and meeting evolving patient demands for minimally invasive treatments, driving innovation and competitiveness in the global biliary stents market. Some of the prominent players operating in the biliary stents market include

• Boston Scientific Corporation
• Cook Medical LLC
• Medtronic plc
• R. Bard (acquired by BD)
• Taewoong Medical Co., Ltd.
• Conmed Corporation
• ELLA-CS, s.r.o.
• Olympus Corporation
• Merit Medical Systems, Inc.
• Micro-Tech (Nanjing) Co., Ltd.
• Allium Medical Solutions Ltd.
• Medi-Globe GmbH
• ENDO-FLEX GmbH
• ETERMED
• Xlumena Inc. (acquired by Boston Scientific)
• Medi-Globe Technologies GmbH
• M.I. Tech Co., Ltd.
• Gadelius Medical K.K.
• Optimed Medizinische Instrumente GmbH
• Dispomedica GmbH

Latest Developments

• In February 2023, Olympus Corporation announced the acquisition of Taewoong Medical, a South Korean manufacturer of gastrointestinal (including biliary tract) metallic stents. Taewoong will receive $370 million in cash under the agreement, with $255.5 million paid at closing and the remaining $114.5 million paid based on future milestones.
• In May 2021, amg International GmbH, a wholly owned subsidiary of Dublin, Ireland-based Q3 Medical Devices Limited (Q3), strengthens its position as a leader in the rapid development of novel biodegradable implants. The Company announced that its second fully biodegradable product, the UNITY-B balloon expandable biodegradable biliary stent (BEBS) for endoscopic use, has received CE Mark approval. The UNITY-B will be used in conjunction with the ARCHIMEDESTM, the world’s first CE-approved pancreaticobiliary biodegradable implant.

Report Scope

Biliary Stents Market, By Category

Product

• Biliary Metal Stents
• Biliary Plastic Stents

End-User

• Hospitals
• Ambulatory Surgical Centers

Application

• Bilio-pancreatic Leakages
• Pancreatic Cancer
• Benign Biliary Strictures
• Gallstones

Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.